Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Release
  • Investors
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Our Culture
  • Press shift tab to select search category

    Loading...
  • Global Australia
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Foundation Ipsen
  • Science
      < Back
    • Science
    • Therapeutic Areas
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibility
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patients
  1. Home
  2. Company
  3. Leadership
  4. Michael Grant

Michael Grant

Post navigation

Previous
Next
Michael Grant

Michael Grant

  • Head of Strategy and Business Excellence
  • Follow in LinkedIn

Michael is a pharmacist by training, with postgraduate diplomas in Business Administration and Computing. He has over 25 years of experience in the pharmaceutical industry. He is inspired by the positive impact of the combination of science, innovation and strategy has on people’s lives. He started his career at GSK in Medical Affairs, before being attracted to the opportunity to contribute through Commercial roles . ​

IPN price

€102.80

 €-0.70 (-0.68%)

  • Media
  • Investors
  • Careers
  • Annual Report
  • Contact us
  • Distribution

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and conditions
  • Cookie Policy
  • Privacy Policy

© Ipsen Pharma. All rights reserved - 2025 Date of preparation: April 2024 CRSC-AU-000016

You are now leaving the Ipsen Australia website. To continue, please click on Continue?

Continue